Sara Tolaney to Present ASCENT-4 Trial Results at ASCO26 – Dana-Farber’s Breast Oncology Center
Sara Tolaney/ X

Sara Tolaney to Present ASCENT-4 Trial Results at ASCO26 – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

Dr. Sara Tolaney  will discuss results of the ASCENT-4 trial during the rapid oral session at ASCO26.

Sunday, May 31

11:30 – 11:36 AM CDT (12:30 – 12:36 PM EST)

Hall D1.

Sara Tolaney to Present ASCENT-4 Trial Results at ASCO26 - Dana-Farber’s Breast Oncology Center

WSG TP-II Trial: Excellent 5-Year Survival After De-Escalated Neoadjuvant Therapy In HR+/HER2+ Early Breast Cancer
Sara Tolaney to Present ASCENT-4 Trial Results at ASCO26 - Dana-Farber’s Breast Oncology Center